A DOUBLE BLIND MULTICENTRIC RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF VRP 1620 IN INCREASING THE SENSITIVITY OF SCREEN FILM MAMMOGRAPHY AND LATERAL CHEST X RAY IN PATIENTS OF BREAST CANCER.
Phase of Trial: Phase III
Latest Information Update: 28 Sep 2016
Price : $35 *
At a glance
- Drugs VRP 1620 (Primary)
- Indications Breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Venus Remedies
- 12 Sep 2016 Status changed from recruiting to completed.
- 28 Apr 2014 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
- 20 Jan 2014 New trial record